Governance: The Glue to a Successful Launch
At the core of every successful launch lies a meticulously crafted plan, a…
Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a…
Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it…
Pandemic-Inspired Thought Bubbles
As we emerge, slowly, into a new phase of the pandemic, there are many “thought bubbles” popping up — viewpoints, concerns, and ideas that we share…
Rare Diseases — It’s All About the Patient
Among all the days of the calendar, February 29th is the rarest of them all. That's why, back in 2008, on the 25th anniversary of the Orphan Drug…
Planning Amidst the Mayhem
Maybe you noticed – 2020 was a crazy year. Like meeting the Pope or becoming a parent for the first time, the phrase "once in a lifetime" keeps…
Just Do It… the Best You Can with Compassion for Others AND Yourself
With six weeks left in the year, this newsletter should be all about getting in gear for the 2021 planning cycle. Or, maybe, it should be about Q1,…
Reverse Mentoring with Up-and-Coming Talent
In the accelerated, high-stakes world of biopharma, thinking big, thinking fast, and thinking smart, isn’t just an option — it’s a priority. Why…
